Enaleni - Cipla Medpro transaction - Competition C
Enaleni - Cipla Medpro transaction - Competition Commission Clearance
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni" or "the company")
Warning: The listing of ordinary shares in the company is on ALTx. Investors
are advised of the risks of investing in a company listed on ALTx. Investors are
advised that the JSE does not guarantee the viability or the success of a
company listed on ALTx. In terms of the Listings Requirements, the company is
obliged to appoint and retain a Designated Adviser, which is required to, inter
alia, attend all board meetings held by the company to ensure that all the
Listings Requirements and applicable regulations are complied with, approve the
Financial Director of the company and guide the company in a competent,
professional and impartial manner. If the company fails to retain a Designated
Adviser, it must make arrangements to appoint a new Designated Adviser within 10
business days, failing which the company faces suspension of trading of its
securities. If a Designated Adviser is not appointed within 30 days of its
suspension, the company faces the termination of its listing without the
prospect of an appropriate offer to minority shareholders.
CIPLA MEDPRO TRANSACTION - COMPETITION COMMISSION CLEARANCE
Shareholders are advised that, further to the announcement dated 26 September
2005, in terms of which Enaleni announced the acquisition of 100% of the
ordinary shares in Cipla Medpro Holdings (Pty) Limited ("Cipla Medpro") from
S.T.D. Pharma Limited and Shelsley Chemicals (Pty) Limited ("the Cipla Medpro
vendors"), for a purchase consideration of R1.2 billion ("the Cipla Medpro
transaction"), a further condition precedent to the Cipla Medpro transaction has
been satisfied, namely the unconditional approval of the transaction by the
Competition Commission authorities, notification of which was received by
Enaleni on Friday, 28 October 2005.
Independent Designated Adviser, Investment Bank and Joint Corporate Adviser and
Arranger
Nedbank Capital
Designated Adviser and Joint Corporate Adviser and Arranger
Exchange Sponsors
Attorneys
Deneys Reitz Inc
Johannesburg
1 November 2005
Date: 01/11/2005 07:05:17 AM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
